Lantheus Medical Imaging Inc. announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator) generators.
Two new 1.5T MRI scanners from GE Healthcare, the Optima MR360 Advance and Brivo MR355 Inspire, have recently received 510(k) clearance. Redesigned with new enclosures symbolizing GE’s Humanizing MRI strategy, both systems are engineered to address the demand for increased performance and reduced total cost of ownership for the facility, while providing a comfortable experience for the patient.
Navidea Biopharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek (technetium Tc 99m tilmanocept) Injection, a novel product indicated for use in lymphatic mapping procedures to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or melanoma. Lymphoseek is a receptor targeted radiopharmaceutical designed to identify these lymph nodes, which have the highest probability of harboring cancer and thereby assist physicians in the staging of such patients.
Clinicians and referring physicians need fast, secure access to both patient data and their diagnostic or viewing tool ...
The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Fourth in the list, they ask that patients and their doctors talk about the real need for a stress echocardiogram if they do not present conditions that would warn them of a risk of heart disease.
For more than three decades various forms of robotics have been effectively applied in healthcare to advance different types of medical treatment and surgical processes. Now, the nation’s first robotic positioning arm for proton therapy is being used by Loma Linda University Medical Center (LLUMC) to provide physicians improved access to tumors typically regarded as difficult to reach and treat.
Hologic Inc. announced the results of an independent survey by KLAS Research of Hologic 3-D mammography sites in the United States. The in-depth survey, which was not commissioned by Hologic, included fifty respondents whose facilities had used Hologic's 3-D mammography (breast tomosynthesis) technology for at least one year. The researcher reported that "providers are seeing cancers that they would not previously have seen with traditional digital mammography," and concluded that providers who are considering 3-D mammography "would benefit by quickly jumping on the bandwagon."
The Healthcare Information and Management Systems (HIMSS24) Conference and Exhibition (March 12-14, in Orlando, Fla.) is ...
EOS imaging announced that its next-generation sterEOS 3-D imaging software, sterEOS 1.5, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The sterEOS 1.5 software was highlighted along with the full EOS Imaging System at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 19-23 in Chicago, Ill. The technology is also featured in a paper submitted for the Hip Society Awards, which was presented on Saturday, March 23.
As Americans celebrate National Colorectal Cancer Awareness Month (March), the Colon Cancer Alliance, Colontown — a survivor/patient support group for colorectal disease, including cancer — and the American College of Radiology (ACR) call on Congress to pass the Computed Tomography (CT) Colonography Screening for Colorectal Cancer Act (H.R. 991). Introduced recently by Reps. Ralph Hall (TX-04) and Danny Davis (D-IL), H.R. 991 would require Medicare to cover beneficiaries for CT colonography — otherwise known as virtual colonoscopy.
Fujifilm SonoSite Inc. announced the launch of AxoTrack Needle Guidance Technology on select SonoSite Ultrasound Systems. This newly developed product, named by Popular Science Magazine as one of 2012’s best new innovations, is now available for use with SonoSite M-Turbo Ultrasound Systems.
Agfa Radiology Solutions is committed to enhancing clinical outcomes and operational efficiency, underscoring its ...
The American College of Radiology (ACR) has affirmed its support for the Diagnostic Imaging Services Access Protection Act (S. 623) recently introduced in the Senate by Senators Ben Cardin (D-MD) and David Vitter (R-LA).
Piramal Imaging SA, a division of Piramal Enterprises, announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted its applications for review of the investigational positron emission tomography (PET) amyloid imaging agent [18F] florbetaben. A New Drug Application (NDA) was submitted to the FDA and a Marketing Authorization Application to the EMA for [18F] florbetaben use in the visual detection of beta-amyloid in the brains of adults with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline. [18F] florbetaben binds to beta-amyloid plaques in the human brain, a hallmark characteristic in Alzheimer's disease.
FujiFilm Medical Systems U.S.A. Inc. showcased its Synapse 3D at the American College of Cardiology (ACC) conference March 9 to 11, 2013 at the Moscone Center in San Francisco, Calif. Fully integrated with Synapse Cardiovascular, Synapse 3D will appeal to cardiologists and cardiovascular specialists interested in advanced visualization and analysis for their diagnostic needs.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) launched a new online resource for imaging professionals, referring physicians and the public on dose optimization for nuclear medicine and molecular imaging procedures.
TeraMedica announced a Partner Agreement with Frontier Solutions Group. FrontierSG now offers complete VNA solutions including integrated storage products from IBM and TeraMedica’s Evercore Clinical Enterprise Suite, the leading vendor neutral archive (VNA) in the industry.
The American Society of Echocardiography (ASE) released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Third in the list, they ask that patients and their doctors talk about the real need for an echocardiogram when preparing for a surgery.
For many patients, diagnosing their back, hip or knee pain is best accomplished by imaging anatomy in a weight-bearing, or standing, position. At the 2013 Annual Meeting of the American Academy of Orthopedic Surgeons in Chicago, Esaote introduces the new G-scan Brio with eXP technology to give physicians a cost-effective tool for performing both traditional and weight-bearing musculoskeletal magnetic resonance imaging (MRI) exams.
The LumaGEM Molecular Breast Imaging (MBI) business of Gamma Medica Inc. has been acquired through a chapter 11 sale by Imaging Acquisition Inc., an entity controlled by healthcare growth equity firm Psilos Group Managers LLC. Molecular breast imaging is an adjunct technology to mammography which radiologists use to help diagnose cancerous lesions in women with dense breast tissue. Already used in 15 prestigious medical institutions and clinical practices throughout the United States, the acquisition and investment by Psilos will enable the more focused company to meet the rapidly growing demand for LumaGEM.
McKesson highlighted enhancements to its cardiovascular information system (CVIS) version 13. The system offers new ...
Only one radiological modality – mammography – is used today for screening. Yet, as America hurdles toward preventive medicine, screening is where it will be at. Now researchers in Cleveland are floating the idea of using MRI as a standard procedure in annual checkups.
Virginia has amended its breast density inform law to include language in information given to patients explaining the risk of dense breast tissue. Originally signed into law by Gov. Bob McDonnell in 2012, the amendment strengthens the density notification to women and is modeled after laws in New York and California. The amendment to the law becomes effective July 1, 2013.